4DMedical Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, 4DMedical stock has a consensus rating of "Hold" and an average price target of $4.97. The average 1-year stock price forecast is 3.97% higher than the current stock price, while the lowest is $3.00 (-37.24%) and the highest is $6.00 (+25.52%).

Price Target: $4.97 (+3.97%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$3.00	$4.97	$5.90	$6.00
Change	-37.24%	+3.97%	+23.43%	+25.52%

Analyst Ratings

The average analyst rating for 4DMedical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tom Godfrey Ord Minnett	Ord Minnett	Sell Maintains $3.00	Sell	Maintains	$3.00	-37.24%	Jun 3, 2026
John Hester Bell Potter	Bell Potter	Buy Maintains $6.00	Buy	Maintains	$6.00	+25.52%	Jun 2, 2026
Jennifer Xu Jefferies	Jefferies	Hold Downgrades $5.90	Hold	Downgrades	$5.90	+23.43%	Apr 23, 2026

Financial Forecast

Revenue This Year

8.34M

from 5.85M

42.48%

from 5.85M

Revenue Next Year

22.25M

from 8.34M

166.83%

from 8.34M

EPS This Year

-0.08

from -0.14

EPS Next Year

-0.06

from -0.08

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	216.98K	1.05M	718.58K	3.75M	5.85M	8.34M
Revenue Growth	-82.40%	385.90%	-31.84%	422.45%	55.91%	42.48%
Gross Profit	125.13K	280.62K	684.44K	3.52M	5.39M	7.71M
Gross Margin	57.67%	26.62%	95.25%	93.69%	92.07%	92.50%
Operating Income	-24.34M	-36.75M	-44.57M	-45.03M	-47.50M	-43.56M
Net Income	-21.42M	-24.59M	-31.46M	-35.98M	-30.07M	-177.05M
EPS	-	-	-	-	-0.14	-0.08
Free Cash Flow	-20.39M	-26.23M	-20.53M	-17.01M	-27.65M	-42.95M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	11.0M
Avg	8.3M
Low	7.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	87.9%
Avg	42.5%
Low	19.6%

EPS Forecast

EPS	2026	2027	2028
High	-0.06
Avg	-0.08
Low	-0.09

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-